Give by midnight, Dec. 31, and your tax-deductible gift will be DOUBLED for kids!
Dramatic advances in cancer research and treatment over the past two decades have made it possible for more children to survive a cancer diagnosis. This reality fuels the lifesaving scientific research and clinical trials conducted at the Cancer and Blood Disease Institute. Our goal is to discover, develop and deliver new approaches to curing pediatric cancer and blood diseases.
Our bench to bedside and back to bench approach to problem-solving integrates scientific and clinical expertise—taking the best ideas from laboratory to the patient in the form of promising new treatments. The basic and translational research faculty members are working to discover and develop new ways to treat pediatric cancer and blood diseases.
Learn more about our extensive research program.
The Clinical Trials Program gives patients access to the latest research protocols and promising therapies for children with cancer and blood disorders. By focusing on investigator-initiated trials, our world-class physician scientists are driving the innovation and science that will improve and save children’s lives worldwide.
View our open clinical trials.
We are the leading international pediatric consortia to include:
The CBDI is expanding its international leadership in pediatric cancer and blood disorders as a principal member of 13 research consortia. By working with these collaborative groups, we are more easily able to reach our goal to speed the pipeline from discovery in the laboratory to the bedside, giving children a better chance of survival and an improved quality of life during and after treatment.